Author

C. Cano

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3 Biochemistry· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

K. AboulFotouh· 3 shared R. O. Williams· 3 shared Z. Cui· 3 shared D. Olive· 2 shared G. Williams· 2 shared H. Xu· 2 shared J. Suman· 2 shared L. Gorvel· 2 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

K. AboulFotouh

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Feasibility of intranasal delivery of thin-film freeze-dried monoclonal antibodies

Y.-S. Yu, H. Xu, K. AboulFotouh, G. Williams, J. Suman, S. Sahakijpijarn, C. Cano, Z. Warnken, K. C.- W. Wu, R. O. Williams, Z. Cui

This paper demonstrates the feasibility of intranasally delivering monoclonal antibodies as dry powders using thin-film freeze-drying and the UDS Powder Nasal Spray System.

bioRxiv · Oct 23, 2023 · PreprintPharmacology & Toxicology

Targeting BTN2A1 enhances Vγ9Vδ2 T cell effector functions and triggers tumor cells pyroptosis

A. C. le Floch, C. Imbert, N. Boucherit, L. Gorvel, S. Fattori, F. Orlanducci, A. Le Roy, L. Archetti, L. Crescence, L. Panicot-Dubois, C. Dubois, N. Vey, A. Briantais, A. Anastasio, C. Cano, , D. Olive

bioRxiv · Jun 15, 2023Cancer Biology

Optimization of RNA Pepper sensors for the detection of arbitrary RNA targets

A. Tang, A. Afasizheva, C. Cano, K. Plath, D. L. Black, E. Franco

This paper develops and optimizes Pepper RNA sensors for detecting arbitrary RNA targets with high brightness and sensitivity.

bioRxiv · Jun 1, 2023Biochemistry

Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive AS01B-adjuvanted vaccine powders

Y.-S. Yu, K. AboulFotouh, G. Williams, J. Suman, C. Cano, Z. N. Warnken, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can convert a liquid vaccine into a dry powder with mucoadhesive properties, which can be effectively delivered using a nasal device for intranasal vaccination.

bioRxiv · Nov 1, 2022 · PreprintPharmacology & Toxicology

Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients

L. Gay, M.-S. Rouviere, S. Mezouar, M. Richaud, L. Gorvel, E. Foucher, L. Madakamutil, B. La Scola, A. Menard, J. Allardet-Servent, P. Halfon, P. Frohna, C. Cano, J.-L. Mege, D. Olive

This paper investigates how SARS-CoV-2 affects Vγ9Vδ2 T cells in patients and shows that anti-BTN3A activation enhances their antiviral response.

bioRxiv · Apr 15, 2022 · PreprintImmunology

Formulation of Dry Powders of Vaccines Containing MF59 or AddaVax by Thin-Film Freeze-Drying

K. AboulFotouh, N. Uno, H. Xu, C. Moon, S. Sahakijpijarn, D. J. Christensen, G. J. Davenport, C. Cano, T. M. Ross, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can convert MF59 or AddaVax-adjuvanted vaccines into dry powders while preserving immunogenicity and stability.

bioRxiv · Oct 21, 2021 · PreprintPharmacology & Toxicology